The phase II LIGHTWAVE study evaluating Sage Therapeutics' dalzanemdor for treating cognitive issues due to Alzheimer's disease fails to meet the primary goal.

Sage Therapeutics’ share price fell 11% to $6 in pre-market activity on Tuesday, after it announced disappointing top-line ...

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the ...

SAGE Therapeutics (SAGE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Douglas ...

Former Columbia University psychiatrist Bret Rutherford, MD, committed research misconduct by "falsely reporting that all ...

Bank of America Securities analyst Tazeen Ahmad has reiterated their bearish stance on SAGE stock, giving a Sell rating on October 4. Tazeen ...

October 9, 2024 • Researchers work to grow grass that will offer the same level playing field for athletes at the various soccer venues that will be used during the 2026 FIFA World Cup October 9 ...

Three refugees, including a Syrian national and a 11-month-old child, suffered burns as they were attacked with acid during an argument with residents in west Delhi's Vikaspuri, police said on ...

On this day, in Game 2 of the 1909 World Series, Ty Cobb stole home base. The details around this famous of all capers ...

The Georgia Supreme Court reinstated the state's six-week abortion ban, overturning a lower court ruling that allowed abortions to continue beyond that time period in a woman's pregnancy. According to ...